| |
| |
|
| Insider
Information: |
Jones Evan/ Fa |
| Relationship: |
Director |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
112,146 |
|
|
Indirect Shares
|
448,791 |
|
|
| Direct
Value |
$842,087 |
|
|
|
Indirect Value
|
$1,644,804 |
|
|
| Total
Shares |
560,937 |
|
|
| Total
Value |
$2,486,892 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -18.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Digene Corp |
DIGE |
Director |
2007-07-30 |
7,160 |
2007-07-26 |
0 |
Premium* |
|
|
CAS Medical Systems Inc |
CASM |
Director |
2013-06-24 |
44,768 |
2013-06-24 |
333,333 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
Director |
|
0 |
2017-07-31 |
58,551 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director |
2024-03-01 |
37,601 |
2024-03-01 |
35,173 |
Premium* |
|
|
Foundation Medicine, Inc. |
FMI |
Director |
2018-07-31 |
0 |
2018-07-31 |
0 |
Premium* |
|
|
Opgen Inc |
OPGN |
Director |
2021-05-17 |
22,617 |
2020-10-27 |
21,734 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2024-03-01 |
4 |
S |
$24.36 |
$243,599 |
D/D |
(10,000) |
37,601 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2024-03-01 |
4 |
OE |
$13.19 |
$131,900 |
D/D |
10,000 |
47,601 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-07-19 |
4 |
AS |
$30.17 |
$93,232 |
I/I |
(3,090) |
35,173 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-07-19 |
4 |
AS |
$30.14 |
$25,257 |
D/D |
(838) |
37,601 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-07-18 |
4 |
AS |
$30.19 |
$224,616 |
I/I |
(7,441) |
38,263 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-07-18 |
4 |
AS |
$30.16 |
$70,090 |
D/D |
(2,324) |
38,439 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-07-17 |
4 |
AS |
$30.07 |
$574,106 |
D/D |
(19,095) |
40,763 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-07-17 |
4 |
AS |
$30.07 |
$720,106 |
I/I |
(23,949) |
45,704 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,674 |
59,858 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2022-12-14 |
4 |
AS |
$30.13 |
$18,080 |
D/D |
(600) |
50,184 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2022-12-13 |
4 |
AS |
$30.51 |
$51,197 |
D/D |
(1,667) |
50,784 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2022-11-11 |
4 |
AS |
$30.21 |
$181,357 |
D/D |
(6,000) |
52,451 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
14,731 |
58,451 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2022-01-11 |
4 |
OE |
$4.00 |
$20,000 |
D/D |
5,000 |
43,720 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,720 |
38,720 |
0 |
- |
|
| OPGN |
Opgen Inc |
Director |
– • – |
2021-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
883 |
22,617 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-01-22 |
4 |
OE |
$2.36 |
$11,800 |
D/D |
5,000 |
30,000 |
0 |
- |
|
| OPGN |
Opgen Inc |
Director |
– • – |
2020-10-27 |
4 |
S |
$2.35 |
$4,108 |
I/I |
(1,748) |
21,734 |
0 |
- |
|
| OPGN |
Opgen Inc |
Director |
– • – |
2020-09-04 |
4 |
S |
$2.19 |
$7,910 |
I/I |
(3,612) |
23,482 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
• • – |
2020-08-03 |
4 |
AS |
$35.13 |
$703,117 |
I/I |
(20,000) |
69,653 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
• • – |
2020-07-31 |
4 |
AS |
$35.56 |
$713,306 |
I/I |
(20,000) |
89,653 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
• • – |
2020-07-15 |
4 |
AS |
$29.81 |
$301,192 |
I/I |
(10,000) |
109,653 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
• • – |
2020-07-14 |
4 |
AS |
$28.13 |
$566,847 |
I/I |
(20,000) |
119,653 |
0 |
% |
|
| OPGN |
Opgen Inc |
Director |
– • – |
2020-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
883 |
27,094 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2019-12-17 |
4 |
AS |
$29.26 |
$438,866 |
I/I |
(15,000) |
158,702 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
